Literature DB >> 19684630

Unexpectedly high AUC levels in a child who received intravenous busulfan before stem cell transplantation.

T Nishikawa, Y Okamoto, T Tanabe, Y Shinkoda, Y Kodama, M Higashi, H Hirano, K Arita, Y Kawano.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19684630     DOI： 10.1038/bmt.2009.195

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  2 in total

1.  Pharmacokinetic monitoring is still required for intravenous busulfan in SCT for small children.

Authors:  Masayuki Nagasawa; Noriko Mitsuiki; Toshiaki Ono; Masatoshi Takagi; Hiromi Oda; Masato Yasuhara; Shuki Mizutani
Journal:  Int J Hematol       Date:  2010-04-27       Impact factor: 2.490

2.  Trough level monitoring of intravenous busulfan to estimate the area under the plasma drug concentration-time curve in pediatric hematopoietic stem cell transplant recipients.

Authors:  Erika Watanabe; Takuro Nishikawa; Kazuro Ikawa; Hiroki Yamaguchi; Takanari Abematsu; Shunsuke Nakagawa; Koichiro Kurauchi; Yuichi Kodama; Takayuki Tanabe; Yuichi Shinkoda; Kazuaki Matsumoto; Yasuhiro Okamoto; Yasuo Takeda; Yoshifumi Kawano
Journal:  Int J Hematol       Date:  2015-08-05       Impact factor: 2.490
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.